Latest ACER reports update at 2023-11-20: 2023-Q3 ∙ 2022-Q4 ∙ 2022-Q3
  1. Home
  2. Stock quotes
  3. Acer Therapeutics
  4. Financial Ratios
Acer Therapeutics logo
Acer Therapeutics ACER
$ 0.89 2.71%
mail-toReport an Error

Acer Therapeutics Financial Ratios 2011-2024 | ACER

Annual Financial Ratios Acer Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -0.5 -2.1 -1.8 -1.3 -9.7 -5.0 -0.8 -1.0 -1.5 -1.6 -0.9 -4.2

P/S

 - 25.8 - - - - 2.3 4.5 17.7 20.9 - -

EPS

 -1.7 -1.1 -2.1 -2.9 -2.5 -3.8 -2.7 -2.0 -4.3 -1.2 -1.5 -1.1

EV (Enterprise Value)

 38.2 M 57.8 M 41.2 M 30.1 M 171 M 57.8 M 6.06 M 3.76 M 16.9 M 8.55 M 8.37 M 19.1 M

EBITDA per Share

 -1.56 -1.11 -2.04 -2.96 -2.53 -3.77 -9.86 -20.8 -38.7 -63.7 -112 -74.9

EV/EBITDA

 -3.4 -1.5 -0.9 -7.6 -4.0 -0.5 0.1 -0.9 -0.2 -0.8 -3.1

PEG

 0.04 0.07 -0.06 0.08 -0.28 -0.07 -0.02 -0.02 -0.03 -0.08 0.02 -0.22

P/B

 -0.7 -18.9 4.9 2.1 4.6 3.2 2.5 1.2 3.0 1.3 2.7 3.5

P/CF

 -0.4 -241.1 -2.4 -1.3 -12.4 -5.0 -0.7 -1.1 -1.6 -4.2 -0.8 -4.8

ROE %

 156.54 891.97 -278.27 -160.14 -47.20 -63.55 -294.90 -125.00 -202.34 -80.95 -309.74 -82.95

ROA %

 -225.71 -42.40 -156.60 -137.05 -42.00 -58.25 -206.39 -83.37 -127.54 -63.48 -215.40 -72.23

ROCE %

 146.85 925.29 -269.28 -159.91 -48.16 -62.45 -256.94 -125.77 -173.79 -52.02 -280.07 -82.92

Current Ratio

 0.4 1.0 1.0 4.7 7.7 8.1 3.3 2.8 3.4 7.4 1.9 6.8

DSO

 - - - - - - - - - - - -

DIO

 - - - - - - - - - - - -

DPO

 - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Acer Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.6 -0.33 -0.77 - -0.31 -0.17 -0.64 - -0.23 -0.21 -0.33 - -0.51 -0.56 -0.49 - -0.52 -1.09 -0.79 - -0.43 -0.64 -0.53 - -1.09 -1.29 -1.38 - -0.77 -0.3 -0.31 - -0.42 -0.42 -0.95 - -1.11 -0.15 -0.13 - -0.39 -0.37 -0.58 - -0.4 -0.38 -0.41 - -0.06 -0.06 -0.06

EBITDA per Share

 - - -0.24 - -0.32 -0.46 -0.49 - -0.23 -0.25 -0.33 - -0.51 -0.55 -0.49 - -0.53 -1.1 -0.81 - -0.45 -0.65 -0.53 - -1.05 -1.24 -1.37 - 0.79 -0.29 -0.3 - -0.41 -0.4 -0.93 - -1.09 -0.15 -0.13 - -0.19 -0.33 -0.35 - -0.35 -0.36 -0.4 - -0.05 -0.06 -0.06

ROE %

 158.55 168.71 174.74 162.25 11.03 -181.20 -275.01 -277.73 -349.82 -270.68 -277.40 -202.42 -231.01 -187.51 -177.45 -132.07 -140.87 -121.08 -71.70 -28.36 -43.93 -50.71 -53.96 -44.68 -26.17 7.91 -55.89 -139.11 -168.16 -215.73 -167.01 -92.97 -145.10 -168.17 -195.07 -157.23 -185.05 -160.74 -119.33 -62.68 -144.45 -198.41 -258.92 -239.18 -257.21 -193.47 -139.05 -56.86 -18.03 -20.66 -18.18

ROA %

 -297.00 -224.46 -180.70 -73.32 -83.37 -60.75 -56.95 -28.09 -68.66 -99.17 -130.98 -113.92 -138.38 -122.28 -134.23 -113.03 -120.85 -104.22 -62.32 -25.23 -39.51 -45.95 -49.22 -40.96 -108.94 -162.65 -204.27 -178.29 -197.67 -149.07 -114.01 -62.00 -94.86 -108.34 -124.23 -99.11 -120.92 -109.88 -86.02 -49.15 -106.02 -141.08 -181.87 -166.34 -182.04 -140.87 -106.65 -49.51 -15.70 -17.99 -15.83

ROCE %

 101.91 117.86 185.37 193.11 41.63 -152.77 -308.25 -289.71 -361.32 -281.44 -276.55 -202.21 -231.40 -188.99 -179.61 -134.48 -143.59 -123.51 -73.64 -28.87 -43.91 -49.84 -52.43 -43.61 -62.12 -65.59 -129.99 -176.33 -205.53 -216.22 -167.53 -93.38 -145.54 -168.50 -195.32 -157.39 -171.31 -133.06 -90.23 -39.65 -111.44 -169.31 -231.19 -229.17 -247.20 -193.43 -139.02 -56.84 -18.02 -20.65 -18.16

Current Ratio

 0.2 0.3 0.4 0.4 0.6 0.7 0.8 0.9 1.1 1.1 1.2 2.3 2.3 2.3 2.3 6.9 6.9 6.9 6.9 9.1 9.1 9.1 9.1 12.0 12.0 12.0 12.0 3.4 3.4 3.3 3.3 3.0 3.0 3.0 3.0 2.7 2.7 2.7 2.7 4.6 4.6 4.6 4.6 3.3 3.3 3.3 3.3 7.7 7.7 7.7 7.7

DSO

 - - - - - - - - - 506.9 506.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 5337.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 6926.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 5337.1 - - - - - - - - 506.9 506.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 -1589.4 - - - - - - - - 506.9 506.9 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency